Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biobucks
Biotech
Biopharma won’t stop betting big on M&A earnouts as payouts slow
Biopharmas love to break the news of an M&A deal with a splashy number and added milestones. But how much of that is actually paid out in the end?
Annalee Armstrong
Oct 17, 2023 6:00am
Genentech signs off on $1B biobucks to expand PeptiDream collab
Sep 20, 2023 7:14am
Pfizer inks 10-program deal with Flagship worth $7B in biobucks
Jul 18, 2023 7:00am
Takeda adds F-Star collab to constellation worth up to $1B
Jul 5, 2023 2:00pm
Blackstone, Sutro ink royalty pact worth up to $390M biobucks
Jun 26, 2023 1:47pm
Genfit licenses liver failure drug from Seal Rock in $107M deal
Jun 1, 2023 8:25am